PMCB icon

PharmaCyte Biotech
PMCB

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $934K invested in PharmaCyte Biotech in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

78% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 9

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
$7K
Net Calls
Net Calls Change

Top Buyers

1
+$45

Top Sellers

1
-$400K
2
-$10.2K
3
-$5.37K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5K
5
APC
Aspire Private Capital
North Carolina
-$1.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$298K
2
$255K
3
$130K
4
$77.4K
5
$53.4K
6
$41.6K
7
$40.3K
8
$30.2K
9
$3.84K
10
$2.94K
11
$841
12
$123
13
$58
14
$28
15
$22
16
$8
17
$4
18
$3
19
–
20
–
21
–
22
–
23
–